Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS584573B2 - Zoryubutsunoseihou - Google Patents
[go: Go Back, main page]

JPS584573B2 - Zoryubutsunoseihou - Google Patents

Zoryubutsunoseihou

Info

Publication number
JPS584573B2
JPS584573B2 JP11426875A JP11426875A JPS584573B2 JP S584573 B2 JPS584573 B2 JP S584573B2 JP 11426875 A JP11426875 A JP 11426875A JP 11426875 A JP11426875 A JP 11426875A JP S584573 B2 JPS584573 B2 JP S584573B2
Authority
JP
Japan
Prior art keywords
substance
binder
granulated
granules
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP11426875A
Other languages
Japanese (ja)
Other versions
JPS5238479A (en
Inventor
阪本光男
松野栄仁
茂木佐四郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OTA PHARMA
Original Assignee
OTA PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OTA PHARMA filed Critical OTA PHARMA
Priority to JP11426875A priority Critical patent/JPS584573B2/en
Publication of JPS5238479A publication Critical patent/JPS5238479A/en
Publication of JPS584573B2 publication Critical patent/JPS584573B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)

Description

【発明の詳細な説明】 本発明は比較的低分子量の水に対する溶解性のある物質
の造粒物の製法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing granules of relatively low molecular weight water-soluble substances.

更に詳しく言えば、本発明は分子量500以下の結晶も
しくは結晶性粉末物質で、その物質1gが1ml以上3
0ml未満の水に溶解する性質を有するものの造粒物を
流動層造粒法により製造する方法に関する。
More specifically, the present invention relates to a crystal or crystalline powder substance with a molecular weight of 500 or less, in which 1 g of the substance is 1 ml or more.
The present invention relates to a method for producing a granulated material having the property of dissolving in less than 0 ml of water by a fluidized bed granulation method.

近時、医薬品、農薬、食料品等の分野で、種種の化学物
質を造粒物とする方法が大いに実用化されている。
BACKGROUND ART In recent years, methods of forming various chemical substances into granules have been widely put into practical use in the fields of pharmaceuticals, agricultural chemicals, foods, and the like.

しかしながら、造粒しようとする物質が、比較的分子量
が小さく、シかも水に対する溶解性が比較的大きい結晶
物質もしくは結晶性粉末物質である場合には、造粒物の
硬度を保持するにはその物質粒子間の結合力のみでは不
充分であり、結合剤を用いることが必須ときれていた。
However, if the substance to be granulated is a crystalline substance or crystalline powder substance with a relatively small molecular weight and relatively high solubility in water, it is necessary to maintain the hardness of the granulated material. The bonding force between material particles alone was insufficient, and the use of a binder was considered essential.

特に、近年造粒技術の発達に伴い、従来の造粒技術にお
ける工程、すなわち、造粉成分の混合工程、その混合物
と結合痢との練合工程、造粒工程、乾燥工程を一台の機
械で連続的に行う流動層造粒機が案出され、実用される
ようになった。
In particular, with the development of granulation technology in recent years, the processes of conventional granulation technology, namely, the mixing process of powdering ingredients, the kneading process of the mixture and connective tissue, the granulation process, and the drying process, have been integrated into one machine. A continuous fluidized bed granulator was devised and put into practical use.

この流動層造粒機による造粒物の製造は、造粒しようと
する原料物質(粉体)を入風により流動化させ、これに
結合剤を含む溶液を噴霧し、次いで乾燥することにより
なるものであるが、流動時に、造粒物は種々の衝撃を受
け、その際粉体粒子間の結合が弱いと造粒物の形態を保
持することができず、その造岐物は摩損し、材料物質の
損失を招く。
The production of granulated products using this fluidized bed granulator involves fluidizing the raw material (powder) to be granulated by blowing air, spraying it with a solution containing a binder, and then drying it. However, when flowing, the granules are subjected to various impacts, and if the bonds between the powder particles are weak, the granules cannot maintain their shape, and the granules wear out. resulting in loss of material.

また、造粒物は製品となった後においても運搬、保管の
取扱い上造粒物の破壊、摩損は最も望ましくないことと
なる。
Further, even after the granules have been made into a product, it is most undesirable for the granules to be destroyed or worn out during transportation and storage.

したがって、造粒にあたっては適当な結合剤の使用は必
須となる。
Therefore, it is essential to use an appropriate binder during granulation.

従来、この種め結合剤として繁用されている物質として
は水溶性高外子物質があげられるが、天然高分子物質、
例えばアカシアガム、澱粉、ペクチン、トラガカントガ
ム、寒天、デキストリン、ゼラチン等は品質の不定性や
不純物混入の懸念から望ましいものではなく、一般的に
はポリビニルピロリドン、ポリビニルアルゴール、シジ
ウムカルボキシメチルゼルロース、メチルセルロース、
ヒドロキシプロピルセルロース等の半合成高分子物質ま
たは合成高分子物質が好ましい結合剤として用いられて
いる。
Conventionally, water-soluble high-density substances have been cited as substances frequently used as seed binders, but natural polymer substances,
For example, gum acacia, starch, pectin, gum tragacanth, agar, dextrin, gelatin, etc. are not desirable due to concerns of uncertain quality and contamination with impurities; generally, polyvinylpyrrolidone, polyvinyl algol, psidium carboxymethylcellulose, methylcellulose,
Semi-synthetic or synthetic polymeric materials such as hydroxypropylcellulose are used as preferred binders.

これら結合剤の使用は、造粒物製造時における造粒物の
耐衝撃性を増大し、製品となった後においではその取扱
上の耐破壊性、耐摩損性を増大する一方、製品の使用時
においてはそれが崩壊、分散を妨げる要因となる。
The use of these binders increases the impact resistance of the granules during their production, and increases their fracture resistance and abrasion resistance during handling after they are made into products. At times, this becomes a factor that impedes collapse and dispersion.

したがって、使用時に速かな崩壊が望まれるような造粒
物の製造にあっては、この矛盾した2つの要求を満足す
るような結合剤が特に必要となる。
Therefore, in the production of granules that are desired to disintegrate rapidly during use, a binder that satisfies these two contradictory requirements is particularly required.

特に医薬などにおいて、薬効の早期発現を必要とする場
合、溶出速度を速めなければならず、それには崩擦性も
また要求される一要素となる。
Particularly in medicines, where early onset of drug efficacy is required, the dissolution rate must be increased, and disintegration property is also a required element.

その点において、従来の高分子物質結合剤は全くその要
求を満たすものではなく、またこの要件をみたす結合剤
は見出されていない。
In this respect, conventional polymer binders do not meet this requirement at all, and no binder that meets this requirement has yet been found.

すなわち、従来使用されている高分子物質結合剤は、造
粒成分の溶出速度を遅らせ、薬効の発現を遅らせること
に対しては効果的に機能するが、速かな崩壊と溶出速度
の促進の要請に対しては逆にマイナスの要因となるもの
であった。
In other words, conventionally used polymer binders function effectively in slowing down the elution rate of granulated components and delaying the onset of drug efficacy, but there is a need for rapid disintegration and acceleration of the elution rate. On the contrary, it was a negative factor.

しかも、合成または半合成の高分子物質の使用には人体
内においての安全性が常に要求されるという困難な課題
が存在する。
Moreover, the use of synthetic or semi-synthetic polymeric substances poses the difficult problem of always requiring safety within the human body.

本発明者等は、これら従来技術における種種の問題の存
在の下で、特定の物質の造粒法につき種種の研究を行っ
た結果、本発明に到達したものである。
The present inventors have arrived at the present invention as a result of conducting various studies on granulation methods for specific substances in the presence of various problems in these conventional techniques.

すなわち、本発明の目的は造粒しようとする物質が、造
粒にあたり、必らず結合剤を必要とし、しかもその結合
剤の選択に非常に困難性がある場合に、結合剤を使用す
ることなしに前述の如き従来技術の問題点を解消した造
粒物の製造法を提供することにある。
That is, the purpose of the present invention is to use a binder when the substance to be granulated necessarily requires a binder for granulation, and it is extremely difficult to select the binder. The object of the present invention is to provide a method for producing granulated products that eliminates the problems of the prior art as described above.

本発明は分子量500以下の結晶もしくは結晶性粉末物
質で、その物質1gが1ml以上30ml未満の水に溶
解する性質を有するものの造粒物の流動層造粒法に1よ
る製造方法を提供するものである。
The present invention provides a method for producing granules of crystals or crystalline powder substances having a molecular weight of 500 or less and having the property that 1 g of the substance dissolves in 1 ml or more and less than 30 ml of water using the fluidized bed granulation method. It is.

本発明方法の特徴は上記の造粒物製造にあたり、結合剤
として造粒しようとする上記物質と乳糖と水との混合物
溶液を用い、禾の結合剤をもって造粒しようとする上記
物質と乳糖よりなる混合物を造粒せしめることにある。
The feature of the method of the present invention is that in producing the above granulated product, a mixture solution of the substance to be granulated, lactose and water is used as a binder, and the substance to be granulated and lactose are combined with a binder as a binder. The purpose is to granulate the mixture.

このような特徴により従来の如き結合剤を用いることな
く、しかも結合剤なしでは造粒が不可能な性質を有する
物質の造粒物を製造し得ることは驚くべきことである。
It is surprising that due to these characteristics, it is possible to produce a granulated material without using a conventional binder, and the material has properties that cannot be granulated without a binder.

さらに驚くべきことは本発明方法で得られた造粒物は摩
損性が極めて低く、しかも一方、使用にあたっての崩壊
性および流出速度は極めて高いことである。
What is even more surprising is that the granules obtained by the method of the present invention have extremely low abrasiveness, yet have extremely high disintegration properties and runoff rates during use.

本発明方法において造粒の対象となる物質は分子量50
0以下の結晶もしくは結晶性粉末物質で、その物質19
が1ml以上30ml未満の水に溶解する性質を有する
ものであるが、これらの特定化条件は技術的には次の如
き意味を持つ。
In the method of the present invention, the substance to be granulated has a molecular weight of 50
0 or less crystals or crystalline powder substances, the substance 19
These specific conditions have the following technical meaning.

すなわち、分子量の比較的大きいものは一般に水溶液の
粘度は大になるから造粒物の製造には結合剤の使用は必
要でないか、もしくは結合剤の選択に困難性はない。
That is, since the viscosity of an aqueous solution of a compound having a relatively large molecular weight is generally high, it is not necessary to use a binder in the production of granules, or there is no difficulty in selecting a binder.

これに対し、分子量の比較的小さいものは結合剤を使用
しないと実用に耐え得る造粒物を得ることは不可能であ
り、そして前述の如く、結合剤を使用する場合には製品
(造粒物)の使用目的や所望の効果と関連してその結合
剤の性質と造粒しようとする物質の性質との関係あるい
は使用に際しての結合剤自体の性質が製品用途に与える
影響などからその結合剤の種類の選択が極めて困難なも
のとなる。
On the other hand, if the molecular weight is relatively small, it is impossible to obtain granules that can withstand practical use without the use of a binder. The relationship between the properties of the binder and the properties of the substance to be granulated in relation to the purpose of use and desired effect of the product (product), and the effect that the properties of the binder itself have on the product use, etc. The selection of the type becomes extremely difficult.

したがって、本発明方法の対象物質は分子量の比較的小
さい物質であり、分子量500以下との規定はその目安
を示す条件であることが理解されよう。
Therefore, it will be understood that the target substance of the method of the present invention is a substance with a relatively small molecular weight, and the stipulation that the molecular weight is 500 or less is a condition indicating the standard.

次に、本発明方法の対象物質はその物質1gが1ml以
上30mA未満の水に溶解する性質を有する物質である
Next, the target substance of the method of the present invention is a substance that has the property that 1 g of the substance dissolves in 1 ml or more and less than 30 mA of water.

これよりさらに水に溶解し易い物質は結合剤なしで実用
に耐え得る造粒物の製造が可能となる物質であるから、
本発明の目的の対象となり得す、またこれより難溶の物
質はそれ自体本発明方法によっては造粒し得ないからこ
れも対象となり得ない。
Substances that are more soluble in water than this are those that allow production of granules that can withstand practical use without a binder.
Substances that are less soluble than these, which can be the object of the present invention, are also not possible because they cannot themselves be granulated by the method of the present invention.

水に対する溶解性に関する上述の条件は第八改正日本薬
局方の「水に溶け易いもの」ならびに「やや溶け易いも
の」に相当するものである。
The above-mentioned conditions regarding solubility in water correspond to "easily soluble in water" and "slightly soluble" in the Eighth Edition Japanese Pharmacopoeia.

さらに本発明方法の対象物質は結晶もしくは結晶性粉末
物質であるが、このことは特に前記規定の如き結晶物質
もしくは結晶性粉末物質がその界面性から一般に造粒し
難いものであり、造粒にあたって結合剤を必要とするこ
とからみて、本発明の目的の対象物質たり得ることが理
解されよう。
Furthermore, the target substance of the method of the present invention is a crystal or crystalline powder substance, and this means that the crystalline substance or crystalline powder substance as defined above is generally difficult to granulate due to its interfacial properties, and it is difficult to granulate it. It will be appreciated that in view of the need for a binder, it may be a subject matter for the purpose of the present invention.

本発明方法により、高分子物質結合剤を使用することな
く、造粒物の破壊、摩損に対する抵抗性を保有すること
ができしかも崩壊を速めるための崩壊剤を使用すること
なく使用時の崩壊を容易にすることができるという相矛
盾する2つの要求を完全に満たす造粒物を得ることがで
きる。
The method of the present invention makes it possible to maintain resistance to breakage and abrasion of granules without using a polymeric binder, and to prevent disintegration during use without using a disintegrant to accelerate disintegration. It is possible to obtain a granulated product that completely satisfies the two contradictory requirements of being able to easily produce granules.

以下に本発明方法の一具体化を実施例を以って説明する
が、本発明の目的および効果はこの実施例に特定される
ものでないことはもちろんである。
One embodiment of the method of the present invention will be described below with reference to Examples, but it goes without saying that the objects and effects of the present invention are not limited to these Examples.

実施例 カルバゾスルホン酸ナトリウム100mgと乳糖900
mgとを流動層造粒機にて10分間混合した後、この混
合物24部をとり36部の蒸留水を加え、60℃で完全
に溶解せしめる。
Example Sodium carbazosulfonate 100mg and lactose 900mg
After mixing for 10 minutes with a fluidized bed granulator, 24 parts of this mixture was added with 36 parts of distilled water, and completely dissolved at 60°C.

得られた溶液を結合剤として使用する。The resulting solution is used as a binder.

前述の混合物の残部を流動層造粒機に入れ、流動せしめ
これに上記により調製した結合剤を噴霧し、造粒、乾燥
せしめる。
The remaining part of the mixture described above is placed in a fluidized bed granulator and fluidized, and the binder prepared above is sprayed onto it, followed by granulation and drying.

得られた造粒物は、100〜350μのものの収率95
%を示し、その摩損度は0. 2 %、安息角は38°
、流出速度(g/min)は17. 9 0であった。
The yield of the obtained granules was 95 for those with a size of 100 to 350μ.
%, and its friability is 0. 2%, angle of repose is 38°
, the outflow rate (g/min) is 17. It was 90.

得られた製剤製品におけるカルバゾクロムスルホン酸ナ
トリウムの溶出速度を、米国薬局方■■ナショナルフオ
ーミュラリテイX■の方法に準じて、バスケット金網1
00メッシュ、試験液として第八改正日本薬局方人工胃
液第1液を用いて、上記製剤70mgをバスケット中に
入れ製剤中の薬物の1 0 0%が溶出されるに要する
時間を測定することによりテストした。
The dissolution rate of sodium carbazochrome sulfonate in the obtained formulation product was measured using a basket wire mesh 1 according to the method of the United States Pharmacopoeia
By placing 70 mg of the above preparation into a basket and measuring the time required for 100% of the drug in the preparation to be eluted, using the 8th edition Japanese Pharmacopoeia artificial gastric juice liquid 1 as the test liquid. Tested.

結果は1分40秒であった。The result was 1 minute 40 seconds.

本製剤は乳糖以外の一切の添加物を含まないにも拘わら
ず著しく優れた調剤性と速かな崩壊性と速い溶出速度を
示し、しかもその摩損度は極めて小さい。
Although this preparation does not contain any additives other than lactose, it exhibits excellent dispensing properties, rapid disintegration, and rapid dissolution rate, and has extremely low friability.

Claims (1)

【特許請求の範囲】[Claims] 1 分子量500以下の結晶もしくは結晶性粉末物質で
、その物質1gが1ml以上30ml未満の水に溶解す
る性質を有するものの造粒物の流動層造粒法による製造
方法であつて、造粒の隙の結合剤として造粒しようとす
る上記物質と乳糖と水との混合物溶液を用い、その結谷
剤をもって、造粒しようとする上記物質と乳糖よりなる
混合物を活粒せしめることを特徴とする流動層造粒法に
よる造粒物の製造方法。
1. A method for producing granules of crystals or crystalline powder substances with a molecular weight of 500 or less, which have the property of dissolving in 1 ml or more and less than 30 ml of water, in which 1 g of the substance has a property of dissolving in 1 ml or more and less than 30 ml of water. A fluidizing method characterized in that a solution of a mixture of the substance to be granulated, lactose and water is used as a binder, and the mixture of the substance to be granulated and lactose is granulated using the binding agent. A method for producing a granulated product using a layer granulation method.
JP11426875A 1975-09-23 1975-09-23 Zoryubutsunoseihou Expired JPS584573B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11426875A JPS584573B2 (en) 1975-09-23 1975-09-23 Zoryubutsunoseihou

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11426875A JPS584573B2 (en) 1975-09-23 1975-09-23 Zoryubutsunoseihou

Publications (2)

Publication Number Publication Date
JPS5238479A JPS5238479A (en) 1977-03-25
JPS584573B2 true JPS584573B2 (en) 1983-01-27

Family

ID=14633542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11426875A Expired JPS584573B2 (en) 1975-09-23 1975-09-23 Zoryubutsunoseihou

Country Status (1)

Country Link
JP (1) JPS584573B2 (en)

Also Published As

Publication number Publication date
JPS5238479A (en) 1977-03-25

Similar Documents

Publication Publication Date Title
CA1110972A (en) Tableting of microcapsules
JP3447042B2 (en) Method for producing single substance spherical particles
US3773920A (en) Sustained release medicinal composition
US3907983A (en) Pharmaceutical preparations
JPH06502151A (en) Drug compounding method and pharmaceutical composition
JPS61100527A (en) Film-formable medicinal coating agent aqueous dispersion andmanufacture
JPS6229514A (en) Delayed release granules of pharmaceutically active substances and their production method
NO176125B (en) Process for preparing granules for controlled release oral multiparticulate compositions
UA72922C2 (en) FORMULATION WITH b-CARBOLENE (VARIANTS) AND METHOD FOR TREATING SEXUAL DYSFUNCTION
JPH06501685A (en) Solvent-free orally administered pharmaceutical preparation with sustained release of active substance and method for producing the same
JPS6363350A (en) Coating composition of feed additive for ruminant and coated feed additive
JP2002514600A (en) Oral drug with reproducible release of active substance, comprising gatifloxacin or a pharmaceutically acceptable salt or hydrate thereof
WO1996041628A1 (en) Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast
US3836618A (en) Process for the uniform distribution of a drug on a granulated base
US3857933A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
JPH0813736B2 (en) Method for preparing tablets or dragee compositions containing heat-, light-, and moisture-sensitive active ingredients having a monoclinic crystal structure
JPH03109333A (en) Preparation of compound drugs
JP3130058B2 (en) Masked granules
JPH05229961A (en) Spherical particle, its production and medicine using the same
JPS584573B2 (en) Zoryubutsunoseihou
JP2711528B2 (en) Loxoprofen preparation
JP2006517929A (en) Method for producing agglomerates using melt agglomeration
JPH09295947A (en) Micro spherical particles and method for producing the same
RU2376013C2 (en) Peroral preparation and method of its production
JP5042447B2 (en) Mixed preparation